Myriam Lassalle Selected Research

5- (6- chloro- 2,4- dioxo- 1,3,4,10- tetrahydro- 2H- 9- oxa- 1,3- diazaanthracen- 10- yl)pyrimidine- 2,4,6- trione

3/2010

Use of human cancer cell lines mitochondria to explore the mechanisms of BH3 peptides and ABT-737-induced mitochondrial membrane permeabilization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myriam Lassalle Research Topics

Disease

4	Neoplasms (Cancer) 11/2010 - 01/2008
2	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2008
1	Residual Neoplasm 01/2016
1	Glioma (Gliomas) 11/2010
1	Infections 10/2009

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2009
2	Peptides (Polypeptides)IBA 03/2010 - 10/2009
1	Messenger RNA (mRNA)IBA 11/2010
1	BH3 Interacting Domain Death Agonist ProteinIBA 03/2010
1	ABT-737IBA 03/2010
1	5- (6- chloro- 2,4- dioxo- 1,3,4,10- tetrahydro- 2H- 9- oxa- 1,3- diazaanthracen- 10- yl)pyrimidine- 2,4,6- trioneIBA 03/2010
1	GossypolIBA 03/2010
1	Cytochromes c (Cytochrome c)IBA 03/2010
1	chelerythrineIBA 03/2010
1	2- methoxyestradiol- 3,17- O,O- bis(sulfamate)IBA 01/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2008
1	taxaneIBA 01/2008
1	Docetaxel (Taxotere)FDA Link 01/2008

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2016